Effects of F17464 in acute exacerbation of schizophrenia

Update Il y a 4 ans
Reference: EUCTR2013-005451-32

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the potential efficacy of 40 mg/day of oral F17464 in comparison to placebo over 6 weeks in patients with acute exacerbation of schizophrenia


Inclusion criteria

  • Schizophrenia